Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles

Gene Therapy

Volumn 7, Issue 22, 2000, Pages 1896-1905

  Cohen, H ^a   Levy, R J ^b   Gao, J ^a   Fishbein, I ^a   Kousaev, V ^a   Sosnowski, S ^c   Slomkowski, S ^c   Golomb, G ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

Gene medicine; Nanoparticles; Nonviral gene delivery systems; PLGA; Sustained release; Transfection

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; AGAROSE; ALKALINE PHOSPHATASE; CATION; ETHIDIUM BROMIDE; LIPOFECTAMINE; LIPOSOME; NANOPARTICLE; PLASMID DNA; POLYGLACTIN; POLYMER; POLYVINYL ALCOHOL; PREDNICARBATE; THIAZOLE ORANGE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA STRUCTURE; DRUG FORMULATION; DRUG POTENCY; ENCAPSULATION; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; REPORTER GENE; SUSTAINED DRUG RELEASE;

ANIMALIA;

EID: 0033676359     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301318     Document Type: Article

References (38)

1. Pharmaceutical perspectives of nonviral gene therapy
2. Non-viral gene therapy
3. Nonviral gene therapy: The promise of genes as pharmaceutical products
4. From genes to gene medicines: Recent advances in nonviral gene delivery
5. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
6. Recent advances in liposome technologies and their applications for systemic gene delivery
7. Gene therapy for tissue repair and regeneration
8. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle
9. DNA delivery from polymer matrices for tissue engineering
10. Toward development of a non-viral gene therapeutic
11. Biologically erodable microspheres as potential oral drug delivery systems
12. Microspheres containing plasmid-encoding antigenes elicit cytotoxic T-cell responses
13. DNA-polycation nanospheres as non-viral gene delivery vehicles
14. Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model
15. Pharmaceutical approach to somatic gene therapy
16. Controlled release of plasmid DNA
17. Controlled DNA delivery systems
18. PLGA microspheres containing plamid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization
19. Biodegradation and biocompatibility of PLA and PLGA microspheres
20. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres
21. Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA
22. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-coglycolic acid) microspheres as a novel approach for immunogen delivery
23. Effect of DNA topology on the tranfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes
24. Stability of peptide-condensed plasmid DNA formulations
25. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA
26. Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA
27. Expression of transfected DNA depends on DNA topology
28. New methods of drug delivery
29. Controlled delivery systems for proteins based on poly (lactic/glycolic) microsphers
30. Transfer of genes to humans: Early lessons and obstacles to success
31. Key issues in non-viral gene delivery
32. Plasmid vectors as antiviral vaccines
33. Gene delivery by polymer-encapsulated DNA
34. Characterization of calcium phosphate as a gene carrier (II): Zeta potential and DNA transfection
35. Synthesis of low-polydispersity poly(tetramethylene oxide) using benzil and pyrene derivatives as initiators
36. Receptor-mediated endocytosis of immunoglobulin-coated colloidal gold particles in cultured mouse peritoneal macrophages. Chloroquine and monensin inhibit transfer of the ligand from endocytic vesicles to lysosomes
37. The effects of sucrose loading on lysosomal hydrolases
38. Characterization of plasmid DNA transfer into mouse skeletal muscle: Evaluation of uptake mechanism, expression and secretion of gene products into blood